News

Published on 11 May 2024 on Simply Wall St. via Yahoo Finance

Pulse Biosciences Insiders Added US$9.69m Of Stock To Their Holdings


Article preview image

Quite a few insiders have dramatically grown their holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) over the past 12 months. An insider's optimism about the company's prospects is a positive sign.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

NASDAQ.PLSE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Robert Duggan Spends US$972k On Pulse Biosciences Stock

Those following along with Pulse Biosciences, Inc. (NASDAQ:PLSE) will no doubt be intrigued by th...

Simply Wall St. · via Yahoo Finance 16 Dec 2024

Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest...

Key Insights Pulse Biosciences' significant insider ownership suggests inherent interests in...

Simply Wall St. · via Yahoo Finance 12 Dec 2024

Pulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic...

Total GAAP Costs and Expenses: Increased by $2.4 million to $13.7 million compared to $11.3 milli...

GuruFocus.com · via Yahoo Finance 31 Oct 2024

Pulse Biosciences Insiders Added US$9.69m Of Stock To Their Holdings

Quite a few insiders have dramatically grown their holdings in Pulse Biosciences, Inc. (NASDAQ:PL...

Simply Wall St. via Yahoo Finance 11 May 2024

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript May 11, 2024 Pulse Bioscie...

Insider Monkey via Yahoo Finance 10 May 2024

Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday’s...

Shares of Nuvve Holding Corp. NVVE fell sharply during Monday’s session after the company report...

Benzinga 1 Apr 2024

Earnings call: Pulse Biosciences advances with FDA clearances and trials

Pulse Biosciences, Inc. (NASDAQ: PLSE ) has reported significant regulatory and development...

Investing.com 1 Apr 2024

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript March 28, 2024 Pulse Biosc...

Insider Monkey via Yahoo Finance 1 Apr 2024

Pulse Biosciences announces $60 million rights offering By Investing.com

Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a...

Investing.com 28 Mar 2024

Insiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) must be disappointed as stock fell 26% after...

Key Insights Pulse Biosciences' significant insider ownership suggests inherent interests in comp...

Simply Wall St. via Yahoo Finance 7 Jan 2024